Our research and development process spans from discovery to customer use. We operate a three-step discovery process based on a wide array of technologies and skills, evolving towards molecular microbiology and omics techniques.
Our R&D process
1. Discovery and proof of concept:
- Strain screening and selection
- Functional assays
- Lallemand Aquapharm screening platform
- >12,500 strains
- Ecosystem-specific microbial collections
- Strain characterization and safety
- Strain identity: whole-genome sequencing
- Antibiotic-resistant genes, presence of mobile genetic elements
- Microbial fractions characterization
- Functional properties
- Development of models and methods
- Functional microarrays
- Quantitative real-time PCR
- Dynamic in vitro models
- Diverse type of biomarkers
- In vitro/in vivo proof of concept
- Proof of concept animal and silage trials
- Mini silos trials for forage inoculants

2. Scale-up and registration
- Production scale-up, process optimization
- Internal process optimization and scale-up team
- Internal pilot plants
- State of the art analytical tools: cytometry, cryomicroscopy, differential scanning calorimetry (DSC)
- Product stability and applicability
- Product formulation optimization
- Internal pilot feed processing unit
- Strain and matrix specific analytical methods
- Next generation microbial cell counters
- In vivo efficacy assessment
- Strong collaboration network with research partners to conduct efficacy trials in all livestock species (ruminant, swine, poultry, aquaculture…), companion animals and equine.
- Dedicated large experimental bunker units for forage inoculants
- Products registration
- Dedicated team of territory specific specialists for the preparation of regulatory dossiers

3. Product Deployment
- Modes of action investigation to strengthen product documentation
- Focus on the role of our solutions on microbial ecosystems and associated impact on animal response, such as performance, welfare, immunity, oxidative stress, metabolism etc.
- Controlled in vitro, ex vivo and in vivo studies to understand modes of action for strains in order to optimize and extend applications
- Application of novel biomarkers and sensors to assess products effects beyond animal performance (e.g. animal welfare)
- Applied trials
- Controlled large scale trials
- Pilot farms network in ruminants, swine, poultry, and aquaculture
- Development of audit tools and on-farm services
- Discover our Forward Program
